"Pipeline" Drug Patent Extension Likely Topic For Waxman/Hatch Hearing

The patent life of so-called "pipeline" drugs is one topic expected to be raised at a Waxman/Hatch hearing tentatively scheduled by the House Judiciary/Courts & Intellectual Property Subcommittee for April 15.